IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 301–400 of 839
Storci, G., Carolis, S. D., Papi, A., Bacalini, M. G., Gensous, N., Marasco, E., Tesei, A., Fabbri, F., Arienti, C., Zanoni, M., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0255-8 · Cited by 69
Self-citationRay, K., Újvári, B., Ramana, V., & Donald, J. A. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.04.002 · Cited by 68
Du, Z., Li, J., Wang, L., Bian, C., Wang, Q., Liao, L., Dou, X., Bian, X., & Zhao, R. C. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01700.x · Cited by 68
A functional perspective of nitazoxanide as a potential anticancer drug
Santo, N. D., & Ehrisman, J. A. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.05.005 · Cited by 68
The Stat3 paradox: A killer and an oncogene
Resemann, H. K., Watson, C. J., & Lloyd‐Lewis, B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.029 · Cited by 68
Murali, B., Ren, Q., Luo, X., Faget, D. V., Wang, C., Johnson, R. M., Gruosso, T., Flanagan, K. C., Fu, Y., Leahy, K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0234 · Cited by 67
“IL-6 is a pleiotropic cytokine with a predominantly pro-tumorigenic role in the context of breast cancer and associated bone metastases (35,36).”
Liu, T., Sun, B., Zhao, X., Li, Y., Zhao, X., Liu, Y., Yao, Z., Gu, Q., Dong, X., Shao, B., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0114-t · Cited by 67
p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion
Hong, B., Li, H., Zhang, M., Xu, J., Lu, Y., Zheng, Y., Qian, J., Chang, J. T., Yang, J., & Yi, Q. (2014) · International Journal of Cancer · doi:10.1002/ijc.28958 · Cited by 66
Interleukin-6 Cytokine: A Multifunctional Glycoprotein for Cancer
Zarogoulidis, P. (2013) · Immunome Research · doi:10.4172/1745-7580.1000062 · Cited by 66
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 68
Lee, S. H., Rigas, N. K., Lee, C.-R., Bang, A., Srikanth, S., Gwack, Y., Kang, M., Kim, R. H., Park, N., & Shin, K.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.9755 · Cited by 65
Pires, B. R. B., de Amorim, Í. S. S., Souza, L. D. E., Rodrigues, J. A., & Mencalha, A. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11151 · Cited by 65
Choi, H. S., Kim, J. H., Kim, S., Deng, H., Lee, D., Kim, C.-S., Yun, B., & Lee, D. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22870 · Cited by 65
Dinca, S. C., Greiner, D., Weidenfeld, K., Bond, L., Barkan, D., & Jorcyk, C. L. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01430-x · Cited by 65
Acid β-Glucosidase 1 Counteracts p38δ-dependent Induction of Interleukin-6
Kitatani, K., Sheldon, K. L., Anelli, V., Jenkins, R. W., Sun, Y., Grabowski, G. A., Obeid, L. M., & Hannun, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809500200 · Cited by 65
Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications
Izrailit, J., & Reedijk, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.028 · Cited by 65
Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells
Zhou, W., Wang, G., & Guo, S. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.003 · Cited by 64
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
Ding, Z., & Zhou, G. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/890178 · Cited by 64
Perivascular stem cell niche in head and neck cancer
Ritchie, K., & Nor, J. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.025 · Cited by 63
Lee, C.-R., Lee, S. H., Rigas, N. K., Kim, R. H., Kang, M., Park, N., & Shin, K.-H. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv169 · Cited by 63
Kim, J. H., Choi, H. S., Kim, S., & Lee, D. (2019) · Cancers · doi:10.3390/cancers11101527 · Cited by 63
IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment
Felcher, C. M., Bogni, E. S., & Kordon, E. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031809 · Cited by 64
The two faces of Janus kinases and their respective STATs in mammary gland development and cancer
Wagner, K., & Schmidt, J. W. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.90677 · Cited by 62
Kim, S., Choi, H. S., Kim, J. H., Jeong, D. K., Kim, K.-S., & Lee, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9296439 · Cited by 62
Preventive effect of Lactobacillus reuteri on melanoma
Luo, M., Hu, M., Xu, F., Wu, X., Dong, D., & Wang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109929 · Cited by 62
Werner‐Klein, M., Grujovic, A., Irlbeck, C., Obradović, M. M. S., Hoffmann, M., Koerkel-Qu, H., Lu, X., Treitschke, S., Köstler, C., Botteron, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18701-4 · Cited by 62
Ma, F., Chen, D., Chen, F., Chi, Y., Han, Z., Feng, X., Li, X., & Han, Z. (2015) · Cell Transplantation · doi:10.3727/096368915x687462 · Cited by 57
Wang, C.-A., Harrell, J. C., Iwanaga, R., Jedlicka, P., & Ford, H. L. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0462-2 · Cited by 61
Wang, D., Xu, J., Liu, B., He, X., Zhou, L., Hu, X., Qiao, F., Zhang, A., Xu, X., Zhang, H., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.162 · Cited by 61
Moreira, M. P., Braga, L. D. C., Cassali, G. D., & Silva, L. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.018 · Cited by 61
Kumar, J., Fraser, F. W., Riley, C. B., Ahmed, N., McCulloch, D. R., & Ward, A. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.673 · Cited by 61
Mine, T., Matsueda, S., Li, Y., Tokumitsu, H., Gao, H., Danes, C., Wong, K., Wang, X., Ferrone, S., & Ioannides, C. G. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0623-1 · Cited by 61
Elevated PI3K signaling drives multiple Breast Cancer subtypes
Adams, J. R., Schachter, N. F., Liu, J. C., Zacksenhaus, E., & Egan, S. E. (2011) · Oncotarget · doi:10.18632/oncotarget.285 · Cited by 60
Molecular-Level Tuning of Cellular Autonomy Controls the Collective Behaviors of Cell Populations
Maire, T., & Youk, H. (2015) · Cell Systems · doi:10.1016/j.cels.2015.10.012 · Cited by 60
Iron overload and altered iron metabolism in ovarian cancer
Rockfield, S., Raffel, J., Mehta, R., Rehman, N., & Nanjundan, M. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0336 · Cited by 60
YING, J., Tsujii, M., Kondo, J., Hayashi, Y., Kato, M., Akasaka, T., INOUE, T., Shiraishi, E., INOUE, T., Hiyama, S., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2851 · Cited by 59
Trinschek, B., Lüssi, F., Haas, J., Wildemann, B., Zipp, F., Wiendl, H., Becker, C., & Jonuleit, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077634 · Cited by 59
Chen, H.-Y., Lin, L., Wang, M., Lee, S.-H., Tsai, M., Tsai, C.-C., Liu, W., Chen, T.-C., Yang, Y.-P., Lee, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9890 · Cited by 59
Xu, Y., Liao, C., Liu, R., Liu, J., Chen, Z., Zhao, H., Li, Z., Chen, L., Wu, C.-P., Tan, H. Q., et al. (2019) · Cell Biology International · doi:10.1002/cbin.11061 · Cited by 59
Ledaki, I., McIntyre, A., Wigfield, S., Buffa, F. M., McGowan, S. J., Baban, D. F., Li, J., & Harris, A. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4989 · Cited by 58
Multiscale Models of Breast Cancer Progression
Chakrabarti, A., Verbridge, S. S., Stroock, A. D., Fischbach, C., & Varner, J. D. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0655-8 · Cited by 58
An IL-6 link between obesity and cancer
Ghosh, S. (2013) · Frontiers in Bioscience · doi:10.2741/e628 · Cited by 57
Che, Q., Liu, B., Wang, F., He, Y., Lu, W., Liao, Y. J., Gu, W. T., & Wan, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.080 · Cited by 56
Interleukin-6 as a Prognostic Marker for Breast Cancer: A Meta-analysis
Lin, S., Gan, Z., Han, K., Yao, Y., & Min, D. (2015) · Tumori Journal · doi:10.5301/tj.5000357 · Cited by 56
Kitajima, S., Yoshida, A., Kohno, S., Li, F., Suzuki, S., Nagatani, N., Nishimoto, Y., Sasaki, N., Muranaka, H., Wan, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.124 · Cited by 56
SPARC Stimulates Neuronal Differentiation of Medulloblastoma Cells via the Notch1/STAT3 Pathway
Bhoopathi, P., Chetty, C., Dontula, R., Gujrati, M., Dinh, D. H., Rao, J. S., & Lakka, S. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3395 · Cited by 55
Rudnick, J. A., Arendt, L. M., Klebba, I., Hinds, J. W., Iyer, V., Gupta, P. B., Naber, S. P., & Kuperwasser, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024605 · Cited by 54
Alamgeer, M., Ganju, V., Kumar, B., Fox, J. G., Hart, S. A., White, M. A., Harris, M., Stuckey, J. G., Prodanovic, Z., Schneider, M. E., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3648 · Cited by 57
Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus
Zaalberg, A., Tuchayi, S. M., Ameri, A. H., Ngo, K. H., Cunningham, T. J., Eliane, J.-P., Livneh, M., Horn, T. D., Rosman, I. S., Musiek, A. C. M., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.185 · Cited by 55
Fanelli, G. N., Naccarato, A. G., & Scatena, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00569 · Cited by 55
Zhao, G., Chen, J., Deng, Y., Gao, F., Zhu, J., Feng, Z., Lv, X.-H., & Zhao, Z. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.140 · Cited by 55
Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review)
Xiao, Y., YONG, X., Tang, B., Qin, Y. W., ZHANG, J.-W., Zhang, D., Xie, R., & Yang, S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3280 · Cited by 54
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
Semenza, G. L. (2015) · Clinical Science · doi:10.1042/cs20150451 · Cited by 52
Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation
Kitajima, S., & Takahashi, C. (2017) · Cancer Science · doi:10.1111/cas.13312 · Cited by 55
Xie, C., Zhu, J., Jiang, Y., Chen, J., Wang, X., Geng, S., Wu, J., Zhong, C., Li, X., & Meng, Z. (2019) · Theranostics · doi:10.7150/thno.33812 · Cited by 54
Mammary Development and Breast Cancer: a Notch Perspective
Chen, W., Wei, W., Yu, L., Ye, Z., Huang, F., Zhang, L., Hu, S., & Cai, C. (2021) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-021-09496-1 · Cited by 54
Papi, A., Carolis, S. D., Bertoni, S., Storci, G., Sceberras, V., Santini, D., Ceccarelli, C., Taffurelli, M., Orlandi, M., & Bonafè, M. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24601 · Cited by 53
Self-citationNotch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells
Masiero, M., Minuzzo, S. A., Pusceddu, I., Moserle, L., Persano, L., Agnusdei, V., Tosello, V., Basso, G., Amadori, A., & Indraccolo, S. (2011) · Leukemia · doi:10.1038/leu.2010.323 · Cited by 53
Erin, N., Korcum, A. F., Tanrιöver, G., Kale, Ş., Demır, N., & Köksoy, S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.024 · Cited by 53
The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction
Xiao, Y. Q., Ye, Y.-S., Zou, X., Jones, S., Yearsley, K. H., Shetuni, B., Tellez, J. D., & Barsky, S. H. (2010) · Oncogene · doi:10.1038/onc.2010.405 · Cited by 53
Roy, L. D., Sahraei, M., Schettini, J. L., Gruber, H. E., Besmer, D. M., & Mukherjee, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-225 · Cited by 53
Emerging strategies for cancer immunoprevention
Roeser, J. C., Leach, S. D., & McAllister, F. (2015) · Oncogene · doi:10.1038/onc.2015.98 · Cited by 52
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 53
Gupta, R., Yang, Q., Dogra, S. K., & Wajapeyee, N. (2017) · Oncogene · doi:10.1038/onc.2017.37 · Cited by 53
Fausti, F., Agostino, S. D., Cioce, M., Bielli, P., Sette, C., Pandolfi, P. P., Oren, M., Sudol, M., Strano, S., & Blandino, G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.101 · Cited by 53
Mezquita, B., & Mezquita, C. (2019) · Biomolecules · doi:10.3390/biom9100567 · Cited by 52
Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer
Guarnieri, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155264 · Cited by 52
Self-citationRoy, L. D., Ghosh, S., Pathangey, L. B., Tinder, T. L., Gruber, H. E., & Mukherjee, P. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-365 · Cited by 52
Zheng, Y., Chow, S., Börnert, K., Basel, D., Mikuscheva, A., Kim, S., Fong-Yee, C., Trivedi, T., Buttgereit, F., Sutherland, R. L., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2231 · Cited by 51
Sasser, K., Casneuf, T., Axel, A. E., King, P., Alvarez, J. D., Werbeck, J. L., Verhulst, T., Verstraeten, K., & Hall, B. M. (2016) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s92414 · Cited by 51
Koh, Y. W., & Lee, H. W. (2017) · Medicine · doi:10.1097/md.0000000000006848 · Cited by 51
Sreenivasan, L., Wang, H., Yap, S. Q., Leclair, P., Tam, A., & Lim, C. J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03241-y · Cited by 51
Kim, B., Seo, Y., Kwon, J., Shin, Y., Kim, S., Park, S. J., Park, J. J., Cheon, J. H., Kim, W. H., & Kim, T. I. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23283 · Cited by 51
Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
Wang, L., Jin, Z., Master, R. P., Maharjan, C. K., Carelock, M. E., Reccoppa, T. B. A., Kim, M., Kolb, R. H., & Zhang, W. (2022) · Cancers · doi:10.3390/cancers14133287 · Cited by 51
Cancer Stem Cells Protect Non‐Stem Cells From Anoikis: Bystander Effects
Kim, S., Hong, S., Basse, P. H., Wu, C., Bartlett, D. L., Kwon, Y. T., & Lee, Y. J. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25527 · Cited by 51
Targeting the N otch signaling pathway in cancer therapeutics
Guo, H., Lü, Y., Wang, J., Liu, X., Keller, E. T., Liu, Q., Zhou, Q., & Zhang, J. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12143 · Cited by 50
Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone
Zheng, Y., Basel, D., Chow, S.-O., Fong-Yee, C., Kim, S., Buttgereit, F., Dunstan, C., Zhou, H., & Seibel, M. (2014) · Clinical and Experimental Metastasis · doi:10.1007/s10585-014-9680-3 · Cited by 45
Targeting Notch Signaling for Cancer Therapeutic Intervention
Shao, H., Huang, Q., & Liu, Z. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00007-5 · Cited by 50
Aparicio-Siegmund, S., Sommer, J., Monhasery, N., Schwanbeck, R., Keil, E., Finkenstädt, D., Pfeffer, K., Rose‐John, S., Scheller, J., & Garbers, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1852 · Cited by 49
Ramamoorthy, P., Dandawate, P. R., Jensen, R. A., & Anant, S. (2021) · Biomedicines · doi:10.3390/biomedicines9050482 · Cited by 49
Bao, B., Ahmad, A., Li, Y., Azmi, A. S., Ali, S. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.714774 · Cited by 49
Kanda, K., Komekado, H., Sawabu, T., Ishizu, S., Nakanishi, Y., Nakatsuji, M., Akitake, R., Ohno, M., Hiraoka, Y., Kawada, M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200216 · Cited by 49
Test System for Trifunctional Antibodies in 3D MCTS Culture
Hirschhaeuser, F., Leidig, T., Rodday, B., Lindemann, C., & Mueller-Klieser, W. (2009) · SLAS Discovery · doi:10.1177/1087057109341766 · Cited by 46
D’Uva, G., Bertoni, S., Lauriola, M., Carolis, S. D., Pacilli, A., D'Anello, L., Santini, D., Taffurelli, M., Ceccarelli, C., Yarden, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080742 · Cited by 48
Self-citationCheng, C.-B., Zhang, Q., Zhuang, L.-P., & Sun, J. L. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa099 · Cited by 48
Feng, J., Yu, S., Li, C., Li, Z., & Zhang, Y. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.025 · Cited by 48
Graham, R. A., Gazińska, P., Zhang, B., Khiabany, A., Sinha, S., Alaguthurai, T., Flores‐Borja, F., Vicencio, J. M., Beuron, F., Roxanis, I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204224 · Cited by 47
Hsu, E., Kulp, S. K., Huang, H.-L., Tu, H., Salunke, S. B., Sullivan, N. J., Sun, D., Wicha, M. S., Shapiro, C. L., & Chen, C. (2015) · Neoplasia · doi:10.1016/j.neo.2015.06.001 · Cited by 47
Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma
Mochizuki, D., Adams, A., Warner, K. A., Zhang, Z., Pearson, A. T., Misawa, K., McLean, S. A., Wolf, G. T., & Nor, J. E. (2015) · Oncotarget · doi:10.18632/oncotarget.4477 · Cited by 47
Papi, A., Storci, G., Guarnieri, T., Carolis, S. D., Bertoni, S., Avenia, N., Sanguinetti, A., Sidoni, A., Santini, D., Ceccarelli, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054968 · Cited by 47
Self-citationLissat, A., Joerschke, M., Shinde, D. A., Braunschweig, T., Meier, A., Makowska, A., Bortnick, R., Henneke, P., Herget, G., Gorr, T. A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1564-7 · Cited by 37
Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling
Roy, L. D., Curry, J. M., Sahraei, M., Besmer, D. M., Kidiyoor, A., Gruber, H. E., & Mukherjee, P. (2013) · Breast Cancer Research · doi:10.1186/bcr3412 · Cited by 46
DNA repair: the culprit for tumor-initiating cell survival?
Mathews, L., Cabarcas‐Petroski, S., & Farrar, W. L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9277-0 · Cited by 46
JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer
Chang, W., Ho, B., Hsiao, Y., Chen, J., Yeh, C.-H., Chen, H., Chang, G., Su, K., & Yu, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150355 · Cited by 45
Kozłowska, A. K., Florczak, A., Smialek, M. J., Dondajewska, E., Mackiewicz, A. A., Kortylewski, M., & Dams‐Kozlowska, H. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.07.014 · Cited by 45
Choi, H. S., Kim, J. H., Kim, S., & Lee, D. (2019) · Cells · doi:10.3390/cells8091007 · Cited by 45
Civenni, G., Longoni, N., Costales, P., Dallavalle, C., Inclán, C. G., Albino, D., Núñez, L. E., Morís, F., Carbone, G. M., & Catapano, C. V. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0791 · Cited by 45
Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
Strell, C., Rundqvist, H., & Östman, A. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.654859 · Cited by 44
Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1
Shah, D., Wyatt, D. L., Baker, A. T., Simms, P. E., Peiffer, D. S., Fernandez, M., Rakha, E. A., Green, A. R., Filipovic, A., Miele, L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1952 · Cited by 44
Notch Signaling and the Breast Cancer Microenvironment
Shen, Q., & Reedijk, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55031-8_12 · Cited by 44
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.